Bayesian Capital Management’s Johnson & Johnson JNJ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | – | Sell |
-1,354
| Closed | -$331K | – | 268 |
|
|
2026
Q1 | $331K | Buy |
+1,354
| New | +$315K | 0.4% | 76 |
|
|
2025
Q3 | – | Sell |
-9,700
| Closed | -$1.48M | – | 675 |
|
|
2025
Q2 | $1.48M | Buy |
+9,700
| New | +$1.49M | 0.23% | 127 |
|
|
2024
Q2 | – | Sell |
-20,700
| Closed | -$3.27M | – | 920 |
|
|
2024
Q1 | $3.27M | Buy |
+20,700
| New | +$3.29M | 0.31% | 79 |
|
|
2023
Q4 | – | Sell |
-51,300
| Closed | -$7.99M | – | 892 |
|
|
2023
Q3 | $7.99M | Buy |
51,300
+33,680
| +191% | +$5.56M | 0.91% | 16 |
|
|
2023
Q2 | $2.92M | Sell |
17,620
-16,341
| -48% | -$2.64M | 0.31% | 70 |
|
|
2023
Q1 | $5.26M | Buy |
+33,961
| New | +$5.48M | 0.65% | 18 |
|
|
2022
Q4 | – | Sell |
-3,218
| Closed | -$526K | – | 903 |
|
|
2022
Q3 | $526K | Sell |
3,218
-1,475
| -31% | -$250K | 0.11% | 269 |
|
|
2022
Q2 | $833K | Sell |
4,693
-2,307
| -33% | -$411K | 0.16% | 195 |
|
|
2022
Q1 | $1.24M | Buy |
7,000
+5,564
| +387% | +$947K | 0.19% | 160 |
|
|
2021
Q4 | $246K | Buy |
+1,436
| New | +$235K | 0.08% | 281 |
|
|
2021
Q3 | – | Sell |
-11,767
| Closed | -$1.94M | – | 463 |
|
|
2021
Q2 | $1.94M | Buy |
+11,767
| New | +$1.95M | 0.51% | 42 |
|
|
2021
Q1 | – | Sell |
-32,100
| Closed | -$5.05M | – | 615 |
|
|
2020
Q4 | $5.05M | Buy |
+32,100
| New | +$4.74M | 1.32% | 8 |
|
|
2020
Q1 | – | Sell |
-2,419
| Closed | -$353K | – | 878 |
|
|
2019
Q4 | $353K | Sell |
2,419
-5,181
| -68% | -$703K | 0.06% | 385 |
|
|
2019
Q3 | $983K | Buy |
+7,600
| New | +$1M | 0.19% | 146 |
|
|
2019
Q1 | – | Sell |
-8,764
| Closed | -$1.13M | – | 663 |
|
|
2018
Q4 | $1.13M | Sell |
8,764
-18,436
| -68% | -$2.57M | 0.23% | 134 |
|
|
2018
Q3 | $3.76M | Buy |
+27,200
| New | +$3.61M | 0.62% | 28 |
|
|
2018
Q1 | – | Sell |
-18,800
| Closed | -$2.63M | – | 710 |
|
|
2017
Q4 | $2.63M | Sell |
18,800
-1,400
| -7% | -$195K | 0.54% | 29 |
|
|
2017
Q3 | $2.63M | Buy |
+20,200
| New | +$2.68M | 0.63% | 21 |
|
|
2017
Q2 | – | Sell |
-6,906
| Closed | -$860K | – | 518 |
|
|
2017
Q1 | $860K | Buy |
+6,906
| New | +$825K | 0.41% | 66 |
|
Other funds holding JNJ
Bayesian Capital Management's JNJ Position: Q2 2026 in Review
Bayesian Capital Management sold out of Johnson & Johnson (JNJ) in Q2 2026, closing a stake of 1,354 shares — an estimated $331K sold.
Bayesian Capital Management first reported a position in JNJ in Q1 2017 and held it in 19 quarters. The position peaked at $7.99M in Q3 2023. 4,698 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.
- Bayesian Capital Management reported no remaining Johnson & Johnson position as of Q2 2026 after selling out during the quarter.
- Bayesian Capital Management sold 1,354 Johnson & Johnson shares in Q2 2026, an estimated $331K.
- Bayesian Capital Management first reported a position in Johnson & Johnson in Q1 2017 and held it in 19 quarters.
- Bayesian Capital Management's Johnson & Johnson position peaked at $7.99M in Q3 2023.
- 4,698 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.
Based on Bayesian Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.